The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors - Takeaways - MDSpire

The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors

  • By

  • Violaine Randrian

  • Fabienne Portales

  • Olivier Bouché

  • Simon Thezenas

  • Benoist Chibaudel

  • May Mabro

  • Eric Terrebonne

  • Claire Garnier-Tixidre

  • Christophe Louvet

  • Thierry André

  • Thomas Aparicio

  • Olivier Dubreuil

  • Gregoire Bouché

  • Marc Ychou

  • David Tougeron

  • January 2, 2025

  • 0 min

Share

  • 1

    Gastrointestinal cancers have a low incidence of brain metastases, with colorectal cancer being the most affected primary site.

  • 2

    The METACER study aims to identify prognostic factors affecting overall survival in patients with brain metastases from gastrointestinal cancers.

  • 3

    Data on brain metastases from non-colorectal gastrointestinal cancers are limited, highlighting the need for more comprehensive studies.

  • 4

    Management of brain metastases in gastrointestinal cancers is not standardized and relies on multidisciplinary approaches.

  • 5

    The study enrolled 130 patients with brain metastases, primarily from colorectal and esogastric cancers, to analyze survival outcomes.

Original Source(s)

Related Content